Home Bratislava Medical Journal 2022 Bratislava Medical Journal Vol.123, No.7, p.505–513, 2022

Journal info


 


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.2

 

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.123, No.7, p.505–513, 2022

Title: Could pyrimidine derivative be effective against Omicron of SARS-CoV-2?
Author: Halis KARATAS, Burak TUZUN, Zulbiye KOKBUDAK

Abstract: BACKGROUND: A pyrimidine based Schiff base was examined in this report. Structural and spectral characterizations were done with Gaussian software. Active sites of the compound were determined using molecular electrostatic potential (MEP) maps.
AIM: We focused to determine whether pyrimidine based Schiff base would be an inhibitor against Omicron of SARS-CoV-2 in silico.
RESULTS AND CONCLUSION: As one of the perils the world has seen lately, omicron of SARS-CoV-2, is a complication to be solved. For the sake of that, anti-viral properties of studied pyrimidine based Schiff base compound were investigated with molecular docking calculations. It was found that the quantitative values of the calculated parameters were in the applicable ranges. In accordance with these results, it will be an important guide for future in vitro and in vivo analysis (Tab. 3, Fig. 7, Ref. 70).

Keywords: Pyrimidine, Schiff base, omicron of SARS-CoV-2, DFT, Molecular docking, ADME/T
Published online: 07-Jun-2022
Year: 2022, Volume: 123, Issue: 7 Page From: 505, Page To: 513
doi:10.4149/BLL_2022_081


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.